vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and MicroAlgo Inc. (MLGO). Click either name above to swap in a different company.
MicroAlgo Inc. is the larger business by last-quarter revenue ($26.3M vs $13.8M, roughly 1.9× Gossamer Bio, Inc.). On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs -35.5%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
MicroAlgo Inc. is a technology enterprise specializing in custom algorithm optimization solutions. It mainly serves clients across smart city management, industrial internet, and e-commerce sectors, helping enterprises improve operational efficiency, reduce operating costs, and optimize data processing performance for real business scenarios.
GOSS vs MLGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $26.3M |
| Net Profit | $-47.2M | — |
| Gross Margin | — | — |
| Operating Margin | -333.6% | — |
| Net Margin | -342.3% | — |
| Revenue YoY | 47.1% | -35.5% |
| Net Profit YoY | -43.0% | — |
| EPS (diluted) | $-0.21 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | — | ||
| Q3 25 | $13.3M | — | ||
| Q2 25 | — | $26.3M | ||
| Q4 24 | — | $34.6M | ||
| Q2 24 | $95.8M | $40.8M | ||
| Q1 24 | $0 | — | ||
| Q3 23 | $0 | — | ||
| Q2 23 | $0 | $20.2M |
| Q4 25 | $-47.2M | — | ||
| Q3 25 | $-48.2M | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | $4.2M | ||
| Q2 24 | $49.2M | — | ||
| Q1 24 | $-41.9M | — | ||
| Q3 23 | $-40.0M | — | ||
| Q2 23 | $-42.5M | $-4.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | 26.4% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | 33.0% |
| Q4 25 | -333.6% | — | ||
| Q3 25 | -369.4% | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | 7.0% | ||
| Q2 24 | 54.3% | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | -7.7% |
| Q4 25 | -342.3% | — | ||
| Q3 25 | -362.7% | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | 12.1% | ||
| Q2 24 | 51.4% | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | -23.7% |
| Q4 25 | $-0.21 | — | ||
| Q3 25 | $-0.21 | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | $0.56 | ||
| Q2 24 | $0.22 | — | ||
| Q1 24 | $-0.19 | — | ||
| Q3 23 | $-0.21 | — | ||
| Q2 23 | $-0.45 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $319.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-122.8M | $317.6M |
| Total Assets | $172.2M | $330.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | — | ||
| Q3 25 | $180.2M | — | ||
| Q2 25 | — | $319.4M | ||
| Q4 24 | — | $164.9M | ||
| Q2 24 | $354.5M | $66.7M | ||
| Q1 24 | $244.4M | — | ||
| Q3 23 | $328.9M | — | ||
| Q2 23 | $162.1M | $19.2M |
| Q4 25 | $-122.8M | — | ||
| Q3 25 | $-82.3M | — | ||
| Q2 25 | — | $317.6M | ||
| Q4 24 | — | $144.9M | ||
| Q2 24 | $81.5M | $76.0M | ||
| Q1 24 | $26.7M | — | ||
| Q3 23 | $104.6M | — | ||
| Q2 23 | $-62.8M | $60.4M |
| Q4 25 | $172.2M | — | ||
| Q3 25 | $208.8M | — | ||
| Q2 25 | — | $330.8M | ||
| Q4 24 | — | $176.3M | ||
| Q2 24 | $373.4M | $107.6M | ||
| Q1 24 | $259.4M | — | ||
| Q3 23 | $347.9M | — | ||
| Q2 23 | $181.7M | $71.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | — | ||
| Q3 25 | $-36.2M | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | $4.8M | ||
| Q2 24 | $116.3M | — | ||
| Q1 24 | $-52.3M | — | ||
| Q3 23 | $-34.5M | — | ||
| Q2 23 | $-38.3M | $-3.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | $4.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | 13.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | 1.15× | ||
| Q2 24 | 2.36× | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
